§FMCSR.com
Historical textIn force on Oct. 1, 2008Source: annual CFR editions 2008–2009

§ 40.187 What does the MRO do with split specimen laboratory results?

Wording in the annual edition revised as of Oct. 1, 2008, superseded by the 2010 annual edition.

govinfo, 2008 edition ↗
Before Jan. 1, 2017 the record is one snapshot per annual CFR edition, revised as of October 1. This is the 2008 edition's wording. An amendment that took effect between Oct. 1, 2008 and Oct. 1, 2008 would not appear until the next edition, so check the citations below and the Federal Register for exact effective dates.
What changedOct. 1, 2003 wording → Oct. 1, 2008 wording+599 added−273 removedHide

As anthe MRO, the split specimen laboratory results you receive will fall into five categories. You must take the following actionsaction, as appropriate, when a laboratory reports thesplit followingspecimen results ofto split specimen tests:you.
(a) Reconfirmed.Category (1): InThe thelaboratory casereconfirmed ofone aor reconfirmedmore positiveof testthe forprimary aspecimen drugresults. orAs drugthe metaboliteMRO, reportyou themust reconfirmationreport to the DER and the employee the result(s) that was/were reconfirmed.
(21) In the case of a reconfirmed adulteratedpositive ortest(s) substitutedfor result,drug(s) reportor todrug themetabolite(s), DER and the employeepositive thatis the specimenfinal wasresult.
(2)
adulteratedIn orthe substituted,case either of which constitutes a refusalreconfirmed toadulterated test.or Thereforesubstituted result, “the refusal to test” is the final result.
(3) In the case of a reconfirmedcombination substitutedpositive result,and inrefusal whichto test results, the creatininefinal concentrationresult foris theboth primarypositive specimenand wasrefusal lessto thantest.
(b)
Category 2: mg/dLThe andlaboratory thefailed creatinineto concentrationreconfirm all of the splitprimary specimen isresults betweenbecause, 2as andappropriate, 5 mgdrug(s)/DL,drug inclusive,metabolite(s) reportwere thenot resultdetected; toadulteration thecriteria employerwere asnot “dilute”met; and/or instructsubstitution thecriteria employerwere tonot conduct an immediate recollection under direct observationmet.
(b)
FailedAs tothe Reconfirm:MRO, Drug(s)/Drugyou Metabolite(s)must Notreport Detected. (1) Report to the DER and the employee that boththe teststest must be cancelled.
(21) UsingAs the MRO, you must inform ODAPC of the failure to reconfirm using the format in Appendix D to this part,.
(2)
informIn ODAPCa ofcase where the failuresplit failed to reconfirm.
(c)
Failedbecause tothe Reconfirm:substitution Adulterationcriteria orwere Substitutionnot (asmet appropriate)and Criteriathe Notsplit Met.specimen (1)creatinine Reportconcentration was equal to theor DERgreater andthan the2mg/dL employeebut thatless boththan testsor mustequal beto cancelled.
(2)
5mg/dL, Usingas the formatMRO, inyou Appendixmust, Din addition to step (b)(1) of this partparagraph, informdirect ODAPCthe ofDER to ensure the failureimmediate tocollection reconfirm.
(d)
of Failedanother tospecimen Reconfirm:from Specimenthe notemployee Availableunder fordirect Testing.observation, (1)with Reportno notice given to the DERemployee andof this collection requirement until immediately before the employeecollection.
(3)
thatIn botha testscase mustwhere bethe cancelledsplit failed to reconfirm and the reasonprimary forspecimen's cancellation.
(2)
result Directwas also invalid, direct the DER to ensure the immediate collection of another specimen from the employee under direct observation, with no notice given to the employee of this collection requirement until immediately before the collection.
(3c) UsingCategory the3: formatThe inlaboratory Appendixfailed D to thisreconfirm partall of the primary specimen results, notifyand ODAPCalso ofreported that the failuresplit tospecimen reconfirmwas invalid, adulterated, and/or substituted.
(e1) FailedIn the case where the laboratory failed to Reconfirm:reconfirm Specimenall Resultsof Invalid.the primary specimen results and the split was reported as invalid, as the MRO, you must:
(1i) Report to the DER and the employee that boththe teststest must be cancelled and the reason for the cancellation.
(2ii) Direct the DER to ensure the immediate collection of another specimen from the employee under direct observation, with no notice given to the employee of this collection requirement until immediately before the collection.
(3iii) UsingInform ODAPC of the failure to reconfirm using the format in Appendix D to this part,.
(2)
notifyIn ODAPCthe ofcase where the failurelaboratory failed to reconfirm.
(f)
Failedany toof Reconfirm:the Splitprimary Specimenspecimen Adulterated.results, and the split was reported as adulterated and/or substituted, as the MRO, you must:
(1i) Contact the employee and inform the employee that the laboratory has determined that his or her split specimen is adulterated and/or substituted, as appropriate.
(2ii) Follow the procedures of § 40.145 to determine if there is a legitimate medical explanation for the laboratory finding of adulteration and/or substitution, as appropriate.
(3iii) If you determine that there is a legitimate medical explanation for the adulterated and/or substituted test result, report to the DER and the employee that the test ismust be cancelled.; Usingand inform ODAPC of the failure to reconfirm using the format in Appendix D to this part, notify ODAPC of the result.
(4iv) If you determine that there is not a legitimate medical explanation for the adulterated and/or substituted test result, you must take the following steps:
(iA) Report the test to the DER and the employee as a verified refusal to test. Inform the employee that he or she has 72 hours to request a test of the primary specimen to determine if the adulterant found in the split specimen also is also present in the primary specimen and/or to determine if the primary specimen meets appropriate substitution criteria.
(iiB) Except thatwhen the request is for a test of the primary specimen and is being made to the laboratory that tested the primary specimen, follow the procedures of §§ 40.153, 40.171, 40.173, 40.179, 40.181, and 40.185, as appropriate.
(iiiC) As the laboratory that tests the primary specimen to reconfirm the presence of the adulterant found in the split specimen and/or to determine that the primary specimen meets appropriate substitution criteria, report your result to the MRO on a photocopy (faxed, mailed, scanned, couriered) of Copy 1 of the CCF .
(ivD) If the test of the primary specimen reconfirms the adulteration and/or substitution finding of the split specimen, as the MRO you must report the test result as a refusal to test as provided in §paragraph 40.187(a)(2) of this section.
(vE) If the test of the primary specimen fails to reconfirm the adulteration and/or substitution finding of the split specimen, as the MRO you must cancel the test, following procedures in paragraph (b) of this section.
(d)
FollowCategory 4: The laboratory failed to reconfirm one or more but not all of the proceduresprimary specimen results, and also reported that the split specimen was invalid, adulterated, and/or substituted. As the MRO, in the case where the laboratory reconfirmed one or more of the primary specimen result(s), you must follow procedures in paragraph (ea) of this section and:
(1) Report that the split was also reported as being invalid, adulterated, and/or substituted (as appropriate).
(2) Inform the DER to take action only on the reconfirmed result(s).
(e) Category 5: The split specimen was not available for testing or there was no split laboratory available to test the specimen. As the MRO, you must:
(1) Report to the DER and the employee that the test must be cancelled and the reason for the cancellation;
(2) Direct the DER to ensure the immediate recollection of another specimen from the employee under direct observation, with no notice given to the employee of this collection requirement until immediately before the collection; and
(3) Notify ODAPC of the failure to reconfirm using the format
in Appendix D to this situationpart.
(gf) For all split specimen results, as the MRO you must:
(1)
Enter your name, sign, and date (Step 7) of Copy 2 of the CCF.
(h2) Send a legible copy of Copy 2 of the CCF (or a signed and dated letter, see § 40.163 ) to the employer and keep a copy for your records. Transmit the document as provided in § 40.167.
[6573 FR 7952635973, Dec.June 1925, 2000, as amended at 66 FR 41953, Aug. 9, 2001; 68 FR 31626, May 28, 20032008]

As the MRO, the split specimen laboratory results you receive will fall into five categories. You must take the following action, as appropriate, when a laboratory reports split specimen results to you.

(a) Category 1: The laboratory reconfirmed one or more of the primary specimen results. As the MRO, you must report to the DER and the employee the result(s) that was/were reconfirmed.

(1) In the case of a reconfirmed positive test(s) for drug(s) or drug metabolite(s), the positive is the final result.

(2) In the case of a reconfirmed adulterated or substituted result, the refusal to test is the final result.

(3) In the case of a combination positive and refusal to test results, the final result is both positive and refusal to test.

(b) Category 2: The laboratory failed to reconfirm all of the primary specimen results because, as appropriate, drug(s)/drug metabolite(s) were not detected; adulteration criteria were not met; and/or substitution criteria were not met. As the MRO, you must report to the DER and the employee that the test must be cancelled.

(1) As the MRO, you must inform ODAPC of the failure to reconfirm using the format in Appendix D to this part.

(2) In a case where the split failed to reconfirm because the substitution criteria were not met and the split specimen creatinine concentration was equal to or greater than 2mg/dL but less than or equal to 5mg/dL, as the MRO, you must, in addition to step (b)(1) of this paragraph, direct the DER to ensure the immediate collection of another specimen from the employee under direct observation, with no notice given to the employee of this collection requirement until immediately before the collection.

(3) In a case where the split failed to reconfirm and the primary specimen's result was also invalid, direct the DER to ensure the immediate collection of another specimen from the employee under direct observation, with no notice given to the employee of this collection requirement until immediately before the collection.

(c) Category 3: The laboratory failed to reconfirm all of the primary specimen results, and also reported that the split specimen was invalid, adulterated, and/or substituted.

(1) In the case where the laboratory failed to reconfirm all of the primary specimen results and the split was reported as invalid, as the MRO, you must:

(i) Report to the DER and the employee that the test must be cancelled and the reason for the cancellation.

(ii) Direct the DER to ensure the immediate collection of another specimen from the employee under direct observation, with no notice given to the employee of this collection requirement until immediately before the collection.

(iii) Inform ODAPC of the failure to reconfirm using the format in Appendix D to this part.

(2) In the case where the laboratory failed to reconfirm any of the primary specimen results, and the split was reported as adulterated and/or substituted, as the MRO, you must:

(i) Contact the employee and inform the employee that the laboratory has determined that his or her split specimen is adulterated and/or substituted, as appropriate.

(ii) Follow the procedures of § 40.145 to determine if there is a legitimate medical explanation for the laboratory finding of adulteration and/or substitution, as appropriate.

(iii) If you determine that there is a legitimate medical explanation for the adulterated and/or substituted test result, report to the DER and the employee that the test must be cancelled; and inform ODAPC of the failure to reconfirm using the format in Appendix D to this part.

(iv) If you determine that there is not a legitimate medical explanation for the adulterated and/or substituted test result, you must take the following steps:

(A) Report the test to the DER and the employee as a verified refusal to test. Inform the employee that he or she has 72 hours to request a test of the primary specimen to determine if the adulterant found in the split specimen is also present in the primary specimen and/or to determine if the primary specimen meets appropriate substitution criteria.

(B) Except when the request is for a test of the primary specimen and is being made to the laboratory that tested the primary specimen, follow the procedures of §§ 40.153, 40.171, 40.173, 40.179, 40.181, and 40.185, as appropriate.

(C) As the laboratory that tests the primary specimen to reconfirm the presence of the adulterant found in the split specimen and/or to determine that the primary specimen meets appropriate substitution criteria, report your result to the MRO on a photocopy (faxed, mailed, scanned, couriered) of Copy 1 of the CCF.

(D) If the test of the primary specimen reconfirms the adulteration and/or substitution finding of the split specimen, as the MRO you must report the result as a refusal to test as provided in paragraph (a)(2) of this section.

(E) If the test of the primary specimen fails to reconfirm the adulteration and/or substitution finding of the split specimen, as the MRO you must cancel the test, following procedures in paragraph (b) of this section.

(d) Category 4: The laboratory failed to reconfirm one or more but not all of the primary specimen results, and also reported that the split specimen was invalid, adulterated, and/or substituted. As the MRO, in the case where the laboratory reconfirmed one or more of the primary specimen result(s), you must follow procedures in paragraph (a) of this section and:

(1) Report that the split was also reported as being invalid, adulterated, and/or substituted (as appropriate).

(2) Inform the DER to take action only on the reconfirmed result(s).

(e) Category 5: The split specimen was not available for testing or there was no split laboratory available to test the specimen. As the MRO, you must:

(1) Report to the DER and the employee that the test must be cancelled and the reason for the cancellation;

(2) Direct the DER to ensure the immediate recollection of another specimen from the employee under direct observation, with no notice given to the employee of this collection requirement until immediately before the collection; and

(3) Notify ODAPC of the failure to reconfirm using the format in Appendix D to this part.

(f) For all split specimen results, as the MRO you must:

(1) Enter your name, sign, and date (Step 7) of Copy 2 of the CCF.

(2) Send a legible copy of Copy 2 of the CCF (or a signed and dated letter, see § 40.163) to the employer and keep a copy for your records. Transmit the document as provided in § 40.167.

[73 FR 35973, June 25, 2008]

Amendment history

7 distinct wordings on file since Oct. 1, 2001
  1. [73 FR 35973, June 25, 2008, as amended at 75 FR 59108, Sept. 27, 2010; 88 FR 27646, May 2, 2023]
  2. [73 FR 35973, June 25, 2008, as amended at 75 FR 59108, Sept. 27, 2010]
  3. [73 FR 35973, June 25, 2008, as amended at 75 FR 59108, Sept. 27, 2010]
  4. [73 FR 35973, June 25, 2008, as amended at 75 FR 59108, Sept. 27, 2010]
  5. Oct. 1, 2008 → Oct. 1, 2010annual editions 2008–2009diff vs. previousviewing
    [73 FR 35973, June 25, 2008]
  6. [65 FR 79526, Dec. 19, 2000, as amended at 66 FR 41953, Aug. 9, 2001; 68 FR 31626, May 28, 2003]
  7. Oct. 1, 2001 → Oct. 1, 2003annual editions 2001–2002
    [65 FR 79526, Dec. 19, 2000, as amended at 66 FR 41953, Aug. 9, 2001]

A new entry appears whenever the regulatory words change between government snapshots. Day-precise from the eCFR (2017 onward); before that, one snapshot per annual CFR edition (revised as of October 1). Bracketed citations are the Federal Register history printed with the section.